Understanding The Role of PLEKHG2 in Cell Signaling and Angiogenesis

Target Name: PLEKHG2

NCBI ID: G64857

PLEKHG2

Understanding The Role of PLEKHG2 in Cell Signaling and Angiogenesis

PLEKHG2 (short for poly (L-leucine) repeat-containing G protein-coupled receptor 2) is a protein that is expressed in many different tissues throughout the body. It is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play important roles in cellular signaling. PLEKHG2 is characterized by the presence of a unique repeat array of leucine amino acids, which gives it its name.

The PLEKHG2 gene was identified in the late 1990s as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Since then, numerous studies have demonstrated that PLEKHG2 is involved in a wide range of physiological processes in the body, including cell signaling, angiogenesis, and inflammation.

One of the key functions of PLEKHG2 is its role in cell signaling. PLEKHG2 is a GPCR that is involved in the production of a variety of signaling molecules, including neurotransmitters, hormones, and cytokines. It is thought to play a key role in the regulation of neural circuits, including the transmission of signals in the central nervous system and the peripheral nervous system.

In addition to its role in cell signaling, PLEKHG2 is also involved in the regulation of angiogenesis, the process by which new blood vessels are formed in the body. PLEKHG2 has been shown to play a positive role in the development of new blood vessels, which may contribute to the increased blood flow and oxygenation that can lead to the formation of cancer.

Furthermore, PLEKHG2 is also involved in the regulation of inflammation. PLEKHG2 has been shown to play a key role in the regulation of immune responses, including the regulation of T cell activity. It is also involved in the production of pro-inflammatory cytokines, which may contribute to the inflammatory response that can occur in various diseases.

Despite all of these promising findings, the identification of PLEKHG2 as a drug target remains a challenge. One reason for this is the complexity of the PLEKHG2 gene and its function. PLEKHG2 is a highly conserved protein that is expressed in many different tissues, making it difficult to study its function in isolation. Additionally, the functions of PLEKHG2 are not well understood, which can make it difficult to identify potential drug targets.

In conclusion, PLEKHG2 is a protein that is characterized by the presence of a unique repeat array of leucine amino acids. It is a member of the GPCR family and is involved in a wide range of physiological processes in the body. The identification of PLEKHG2 as a potential drug target for various diseases has generated a significant amount of interest and research in recent years. Further studies are needed to fully understand its function and potential as a drug target.

Protein Name: Pleckstrin Homology And RhoGEF Domain Containing G2

Functions: May be a transforming oncogene with exchange activity for CDC42 (By similarity). May be a guanine-nucleotide exchange factor (GEF) for RAC1 and CDC42. Activated by the binding to subunits beta and gamma of the heterotrimeric guanine nucleotide-binding protein (G protein) (PubMed:18045877). Involved in the regulation of actin polymerization (PubMed:26573021)

The "PLEKHG2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLEKHG2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets